333 related articles for article (PubMed ID: 3082196)
21. Compatibility considerations in parenteral nutrient solutions.
Niemiec PW; Vanderveen TW
Am J Hosp Pharm; 1984 May; 41(5):893-911. PubMed ID: 6328980
[TBL] [Abstract][Full Text] [Related]
22. Stability of ranitidine hydrochloride and amino acids in parenteral nutrient solutions.
Bullock L; Parks RB; Lampasona V; Mullins RE
Am J Hosp Pharm; 1985 Dec; 42(12):2683-7. PubMed ID: 3936354
[TBL] [Abstract][Full Text] [Related]
23. Stability of total nutrient admixtures in a dual-chamber flexible container.
Tripp MG; Menon SK; Mikrut BA
Am J Hosp Pharm; 1990 Nov; 47(11):2496-503. PubMed ID: 2126163
[TBL] [Abstract][Full Text] [Related]
24. Calcium and phosphate compatibility in low-osmolarity parenteral nutrition admixtures intended for peripheral vein administration.
Joy J; Silvestri AP; Franke R; Bistrian BR; Nehne J; Newton DW; Driscoll DF
JPEN J Parenter Enteral Nutr; 2010; 34(1):46-54. PubMed ID: 19846668
[TBL] [Abstract][Full Text] [Related]
25. Stability of Liposyn II fat emulsion in total nutrient admixtures.
Sayeed FA; Johnson HW; Sukumaran KB; Raihle JA; Mowles DL; Stelmach HA; Majors KR
Am J Hosp Pharm; 1986 May; 43(5):1230-5. PubMed ID: 3087165
[TBL] [Abstract][Full Text] [Related]
26. Practice-based validation of calcium and phosphorus solubility limits for pediatric parenteral nutrition solutions.
MacKay M; Jackson D; Eggert L; Fitzgerald K; Cash J
Nutr Clin Pract; 2011 Dec; 26(6):708-13. PubMed ID: 22205559
[TBL] [Abstract][Full Text] [Related]
27. Calcium Chloride in Neonatal Parenteral Nutrition Solutions with and without Added Cysteine: Compatibility Studies Using Laser and Micro-Flow Imaging Methodology.
Huston RK; Christensen JM; Alshahrani SM; Mohamed SM; Clark SM; Nason JA; Wu YX
PLoS One; 2015; 10(8):e0136894. PubMed ID: 26317344
[TBL] [Abstract][Full Text] [Related]
28. Visual compatibility of 30 additives with a parenteral nutrient solution.
Athanikar N; Boyer B; Deamer R; Harbison H; Henry RS; Jurgens R; Mett C; Sturgeon R; VanLeuven M; Welco A
Am J Hosp Pharm; 1979 Apr; 36(4):511-3. PubMed ID: 107797
[TBL] [Abstract][Full Text] [Related]
29. Detection of TPN contamination of dried blood spots used in newborn and metabolic screening and its impact on quantitative measurement of amino acids.
Chace DH; De Jesús VR; Lim TH; Hannon WH; Clark RH; Spitzer AR
Clin Chim Acta; 2011 Jul; 412(15-16):1385-90. PubMed ID: 21514290
[TBL] [Abstract][Full Text] [Related]
30. Calcium/Phosphate Solubility Curves for Premasol and Trophamine Pediatric Parenteral Nutrition Formulations.
Owen HJ; Gonyon TM; Green JD; Patel DH; Eilert JY; Gripman LL; Wyrwa ST
J Pediatr Pharmacol Ther; 2019; 24(1):45-52. PubMed ID: 30837814
[TBL] [Abstract][Full Text] [Related]
31. Stability of ceftazidime and amino acids in parenteral nutrient solutions.
Wade CS; Lampasona V; Mullins RE; Parks RB
Am J Hosp Pharm; 1991 Jul; 48(7):1515-9. PubMed ID: 1909093
[TBL] [Abstract][Full Text] [Related]
32. Growth of bacteria and fungi in total nutrient admixtures.
Scheckelhoff DJ; Mirtallo JM; Ayers LW; Visconti JA
Am J Hosp Pharm; 1986 Jan; 43(1):73-7. PubMed ID: 3082195
[TBL] [Abstract][Full Text] [Related]
33. Emulsion stability in total nutrient admixtures containing a pediatric amino acid formulation.
Bullock L; Fitzgerald JF; Walter WV
JPEN J Parenter Enteral Nutr; 1992; 16(1):64-8. PubMed ID: 1738223
[TBL] [Abstract][Full Text] [Related]
34. Use of Cysteine Hydrochloride Injection To Increase the Solubility of Calcium and Phosphates in FreAmine III-Containing Paranteral Nutrition Solutions.
Trissel LA; Xu Q; Zhang Y; Walter WV
Int J Pharm Compd; 2003; 7(1):71-7. PubMed ID: 23979510
[TBL] [Abstract][Full Text] [Related]
35. Stability of ganciclovir sodium and amino acids in parenteral nutrient solutions.
Johnson CE; Jacobson PA; Chan E
Am J Hosp Pharm; 1994 Feb; 51(4):503-8. PubMed ID: 8017417
[TBL] [Abstract][Full Text] [Related]
36. [A study on factors influencing the stability of total nutrient admixture].
Zhang LH
Zhonghua Wai Ke Za Zhi; 1991 Jun; 29(6):353-6, 396. PubMed ID: 1935432
[TBL] [Abstract][Full Text] [Related]
37. Growth of bacteria and fungi in parenteral nutrition solutions containing albumin.
Mirtallo JM; Caryer K; Schneider PJ; Ayers L; Fabri PJ
Am J Hosp Pharm; 1981 Dec; 38(12):1907-10. PubMed ID: 6798862
[TBL] [Abstract][Full Text] [Related]
38. Stability of nizatidine in total nutrient admixtures.
Hatton J; Holstad SG; Rosenbloom AD; Westrich T; Hirsch J
Am J Hosp Pharm; 1991 Jul; 48(7):1507-10. PubMed ID: 1679293
[TBL] [Abstract][Full Text] [Related]
39. Effect of the intravenous lipid emulsions on the availability of calcium when using organic phosphate in TPN admixtures.
Chaieb D S; Chaumeil JC; Jebnoun S; Khrouf N; Hedhili A; Sfar S
Pharm Res; 2008 Nov; 25(11):2545-54. PubMed ID: 18719980
[TBL] [Abstract][Full Text] [Related]
40. Maximization of calcium and phosphate in neonatal total parenteral nutrition.
Maruyama H; Saito J; Nagai M; Mochizuki M; Ishikawa Y; Ito Y
Pediatr Int; 2018 Jul; 60(7):634-638. PubMed ID: 29654605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
